Leonardo DRS Schedules First Quarter 2023 Earnings Conference Call for May 3, 2023

Rhea-AI Summary

Leonardo DRS, Inc. (Nasdaq: DRS) will hold a conference call on May 3, 2023, at 5:00 p.m. ET to discuss its first-quarter 2023 results. A press release detailing quarterly earnings will be issued before the call. Investors can access the audio broadcast and supporting documents on the company's investor relations website. A replay of the call will be available two hours after its conclusion and will remain accessible for 90 days.

Based in Arlington, VA, Leonardo DRS provides advanced defense technology to U.S. national security clients and global allies, specializing in various high-tech solutions for military applications. The company emphasizes its commitment to developing innovative technologies aimed at tackling emerging defense challenges.

ARLINGTON, Va.--(BUSINESS WIRE)-- Leonardo DRS, Inc. (Nasdaq and TASE: DRS) has scheduled a conference call for Wednesday, May 3, 2023 beginning at 5:00 p.m. (ET) to discuss its first quarter 2023 results. The company plans to issue its quarterly earnings press release prior to the conference call.

The live audio broadcast of the conference call with corresponding press release and supplemental information will be available on the company’s investor relations website. To attend the conference call or webcast, participants should register online at https://investors.leonardodrs.com.

A replay will be available on the company’s website approximately two hours after the conclusion of the conference call and continuing for 90 days.

About Leonardo DRS

Headquartered in Arlington, VA, Leonardo DRS, Inc. is an innovative and agile provider of advanced defense technology to U.S. national security customers and allies around the world. We specialize in the design, development and manufacture of advanced sensing, network computing, force protection, and electric power and propulsion, and other leading mission-critical technologies. Our innovative people are leading the way in developing disruptive technologies for autonomous, dynamic, interconnected, and multi-domain capabilities to defend against new and emerging threats. For more information and to learn more about our full range of capabilities, visit www.LeonardoDRS.com.

Forward-Looking Statements

This communication contains statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Those statements reflect current expectations, assumptions and estimates of future performance and economic conditions. The company cautions investors that any forward-looking statements are subject to risks and uncertainties that may cause actual results and future trends to differ materially from those matters expressed in or implied by such forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230417005036/en/

Leonardo DRS Investor Relations Contact

Steve Vather

Vice President, Investor Relations and Corporate Finance

+1 703 409 2906

stephen.vather@drs.com



Leonardo DRS Media Contact

Michael Mount

Vice President, Communications and Public Affairs

+1 571 447 4624

mmount@drs.com

Source: Leonardo DRS, Inc.

FAQ

When is the upcoming conference call for Leonardo DRS?

The upcoming conference call for Leonardo DRS is scheduled for May 3, 2023, at 5:00 p.m. ET.

What will Leonardo DRS discuss during their conference call?

Leonardo DRS will discuss its first-quarter 2023 results during the conference call.

Where can I find the earnings press release for Leonardo DRS?

The earnings press release for Leonardo DRS will be available on the company's investor relations website before the conference call.

How can I listen to the conference call for Leonardo DRS?

You can listen to the conference call by registering on Leonardo DRS's investor relations website.

Is there a replay available for the Leonardo DRS conference call?

Yes, a replay of the Leonardo DRS conference call will be available approximately two hours after its conclusion for 90 days.